Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Third Rock Ventures, LLC (CIK 1600135) reported $1.07B across 5 reported positions in its SEC 13F filing for 2015-09-30. Largest positions: GBT ($622.3M, 58.10%), SAGE ($272.7M, 25.46%), BPMC ($157.8M, 14.73%), SESN ($11.7M, 1.09%), LRMR ($6.7M, 0.63%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | GBT | GLOBAL BLOOD THERAPEUTICS IN | $622.3M | 58.10% | 14.8M | New |
| 2 | SAGE | SAGE THERAPEUTICS INC | $272.7M | 25.46% | 6.4M | Trimmed |
| 3 | BPMC | BLUEPRINT MEDICINES CORP | $157.8M | 14.73% | 7.4M | Hold |
| 4 | SESN | ELEVEN BIOTHERAPEUTICS INC | $11.7M | 1.09% | 4.8M | Hold |
| 5 | LRMR | ZAFGEN INC | $6.7M | 0.63% | 210,371 | Trimmed |
Source: SEC Form 13F filings · as of 2015-09-30